Burjeel Holdings, a healthcare services provider in the Middle East and North Africa (MENA) region, has announced the launch of the first dedicated Day Surgery Center in Al Dhafra, Abu Dhabi, UAE.
The centre, situated in Madinat Zayed’s Al Dhafra Mall, was inaugurated by the undersecretary of the Ruler’s Representative Court in Al Dhafra Region, Nasser Mohammed Al Mansouri.
The Burjeel Day Surgery Center has been developed to offer a wide range of outpatient procedures that promote quick recovery and reduce the need for extended hospital stays.
This is the fourth such facility opened by Burjeel Holdings in Abu Dhabi, tailored to cater to the specific needs of the local population and geography.
The opening of the centre is supported by Burjeel Medical City (BMC), the flagship quaternary hospital of the group. It will work in tandem with ADNOC’s Al Dhannah Hospital, also operated by BMC, to offer integrated and coordinated care to patients.
Burjeel Day Surgery Center, staffed by board-certified doctors, is equipped with advanced medical technologies for diagnostic and therapeutic procedures.
It offers comprehensive services across 13 specialities, including cardiology, paediatrics, and general surgery, among others.
Furthermore, the centre has a full suite of radiology services and a physiotherapy and rehabilitation department.
Al Mansouri said: “The launch of the Burjeel Day Surgery Center marks a significant step in advancing healthcare services in Al Dhafra, playing a vital role in serving the region’s residents.
“It aligns with the vision of our wise leadership to provide world-class healthcare and promote a healthier, more resilient society.”
Separately, Burjeel Holdings has reported a net profit ex-one-offs & taxes of Dh238m ($64.78m) for the first half (H1) of 2024, marking a 5.9% increase from Dh225m ($61.24m) in H1 2023.
The second quarter (Q2) of 2024 alone saw a net profit ex-one-offs & taxes of Dh97m.
The company's revenue for the reported six-month period ending 30 June 2024 saw a significant year-on-year increase of 10.4% to Dh2.38bn, from Dh2.16bn during the same period last year.
It was driven by strong patient footfall growth and improved patient yield, the company said.
The hospitals segment of Burjeel Holdings also reported revenue growth, with an increase of 9.2% to Dh2.09bn in H1 of 2024 from Dh1.91bn in H1 2023.
In H1 2024, outpatient revenue surged by Dh137m, marking a 10% year-over-year increase, while inpatient revenue climbed by Dh82m, up 11% from the previous year.
The group’s patient footfall grew to 3.1 million during this period, with patient growth accelerating to 11% in Q2 2024.
